Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Nightingale Health partners with Supernormal to add at-home blood testing to Finland weight loss program

Nightingale Health partners with Supernormal to add at-home blood testing to Finland weight loss program

ReutersReuters2026/08/18 07:02
  • Nightingale Health entered a partnership with Supernormal to add its Remote Health Check to Supernormal’s medically supervised weight-loss service in Finland.
  • Members will collect finger-prick blood samples at home; Nightingale Health will analyze them for baseline screening before treatment starts.
  • Repeat testing during the program will track metabolic health changes during treatment, including use of GLP-1 medication.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nightingale Health Oyj published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Agents On XRP. Here’s What Is Happening

TimesTabloid2026/08/18 08:00

AstraZeneca (AZN.US) monoclonal antibody new drug approved for two indications in China

AstraZeneca (AZN.US) announced the official launch of Tezelyumab injection in China.

智通财经2026/08/18 07:56
AstraZeneca (AZN.US) monoclonal antibody new drug approved for two indications in China